Virginia Retirement Systems Et Al Exelixis, Inc. Transaction History

Virginia Retirement Systems Et Al

$10.1 Billion
Q3 2023

A detailed history of Virginia Retirement Systems Et Al transactions in Exelixis, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 132,800 shares of EXEL stock, worth $4.83 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

132,800

Previous 163,500 18.78%

Holding current value

$4.83 Million

Previous $3.12 Million 7.14%

% of portfolio

0.03%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jan 02, 2024	SELL	$19.04 - $22.74 $584,528 - $698,118	-30,700 Reduced 18.78%	132,800 $2.9 Million
Q2 2023 Aug 22, 2023	BUY	$18.17 - $20.48 $950,291 - $1.07 Million	52,300 Added 47.03%	163,500 $3.12 Million
Q1 2023 Jul 11, 2023	BUY	$16.3 - $19.41 $74,980 - $89,286	4,600 Added 4.32%	111,200 $2.16 Million
Q4 2022 May 17, 2023	SELL	$14.96 - $17.39 $164,560 - $191,290	-11,000 Reduced 9.35%	106,600 $1.71 Billion
Q3 2022 May 16, 2023	BUY	$15.68 - $22.27 $663,264 - $942,021	42,300 Added 56.18%	117,600 $1.84 Billion
Q1 2022 Apr 21, 2022	SELL	$17.03 - $22.67 $163,488 - $217,632	-9,600 Reduced 11.31%	75,300 $1.71 Million
Q3 2021 Oct 21, 2021	BUY	$16.3 - $21.14 $128,770 - $167,006	7,900 Added 10.26%	84,900 $1.8 Million
Q2 2021 Aug 13, 2021	SELL	$17.95 - $25.56 $229,760 - $327,168	-12,800 Reduced 14.25%	77,000 $1.4 Million
Q1 2021 Apr 30, 2021	BUY	$20.53 - $25.22 $102,650 - $126,100	5,000 Added 5.9%	89,800 $2.03 Million
Q4 2020 Feb 16, 2021	BUY	$18.39 - $24.8 $261,138 - $352,160	14,200 Added 20.11%	84,800 $1.7 Million
Q3 2020 Nov 12, 2020	SELL	$20.67 - $26.94 $68,211 - $88,902	-3,300 Reduced 4.47%	70,600 $1.73 Million
Q2 2020 Aug 12, 2020	BUY	$16.46 - $27.42 $669,922 - $1.12 Million	40,700 Added 122.59%	73,900 $1.75 Million
Q1 2020 May 12, 2020	SELL	$14.46 - $21.8 $884,952 - $1.33 Million	-61,200 Reduced 64.83%	33,200 $572,000
Q4 2019 Jan 27, 2020	SELL	$15.15 - $18.89 $181,800 - $226,680	-12,000 Reduced 11.28%	94,400 $1.66 Million
Q3 2019 Oct 22, 2019	BUY	$17.68 - $22.65 $912,288 - $1.17 Million	51,600 Added 94.16%	106,400 $1.88 Million
Q2 2019 Jul 26, 2019	SELL	$18.93 - $24.75 $456,213 - $596,475	-24,100 Reduced 30.54%	54,800 $1.17 Million
Q1 2019 Apr 25, 2019	SELL	$19.6 - $24.76 $194,040 - $245,124	-9,900 Reduced 11.15%	78,900 $1.88 Million
Q4 2018 Feb 07, 2019	SELL	$13.65 - $21.8 $57,330 - $91,560	-4,200 Reduced 4.52%	88,800 $1.75 Million
Q3 2018 Nov 02, 2018	BUY	$15.87 - $22.4 $657,018 - $927,359	41,400 Added 80.23%	93,000 $1.65 Million
Q2 2018 Aug 03, 2018	BUY	$18.56 - $22.45 $957,695 - $1.16 Million	51,600 New	51,600 $1.11 Million

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Exelixis, Inc. Transaction History